Medpace Holdings Inc Net Income per Employee (MEDP), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Medpace Holdings Inc   (NASDAQ: MEDP)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Medpace Holdings Inc Net Income per Employee

MEDP's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 34.46% in the second quarter 2026, year on year to cumulative value of $492 million, and with 6,200 employees, Medpace Holdings Inc 's income per employee grew on trailing twelve month basis to $ 79,274, this marks a new company high for all of 6,200 employees.
The Healthcare sector has seen employees of 3 other companies achieving higher income per employee. While Medpace Holdings Inc 's total ranking has deteriorated compared to the previous quarter from 1130 to 1135.


What is Income per Employee Ratio?






MEDP Net Income per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Net Income Change 34.46 % 8.09 % 15.48 % 15.25 % 2.16 %
Net Income per Employee (TTM) $ 79,274 74,258 72,762 69,840 67,468
MEDP's Total Ranking # 1135 # 1130 # 930 # 1069 # 737
Seq. Net Income Change -2.02 % -8.33 % 21.59 % 23.13 % -21.24 %


MEDP Net Income per Employee Company Ranking
Within: No.
Medical Laboratories Industry # 4
Healthcare Sector # 101
Overall Market # 1135

Net Income per Employee Statistics
High Average Low
$ 79,274 $ 36,287 $ 6,310
(Jun 30 2026)   (Dec 31 2017)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Resmed Inc   133,974.76 $ 1,523.293  Million 11,370 
Community Health Systems Inc   132,258.06 $ 410.000  Million 3,100 
Ani Pharmaceuticals Inc  109,895.88 $ 106.599  Million 970 
Entera Bio Ltd   109,500.00 $ 2.409  Million 22 
Idexx Laboratories Inc  103,605.09 $ 1,139.656  Million 11,000 
Progyny Inc   91,860.98 $ 78.633  Million 856 
Globus Medical Inc   89,238.50 $ 535.431  Million 6,000 
Protalix Biotherapeutics inc   83,827.43 $ 18.945  Million 226 
Agilent Technologies inc   79,558.01 $ 1,440.000  Million 18,100 
Alpha Pro Tech Ltd   79,325.20 $ 9.757  Million 123 
Medpace Holdings Inc   79,274.19 $ 491.500  Million 6,200 
Aveanna Healthcare Holdings Inc   78,503.43 $ 274.762  Million 3,500 
Corcept Therapeutics Inc  74,261.64 $ 54.211  Million 730 
Strata Critical Medical Inc   66,923.46 $ 40.221  Million 601 
Stryker Corp  66,589.29 $ 3,729.000  Million 56,000 
Pro dex Inc   66,320.39 $ 13.662  Million 206 
Edwards Lifesciences Corporation  62,725.00 $ 1,003.600  Million 16,000 
Bio techne Corp  60,620.67 $ 181.862  Million 3,000 
Msa Safety Inc  59,246.98 $ 314.009  Million 5,300 
Pfizer Inc  58,266.67 $ 4,370.000  Million 75,000 
Sbc Medical Group Holdings Incorporated  57,479.19 $ 49.605  Million 863 
Electromed Inc   57,365.48 $ 11.301  Million 197 
Utah Medical Products Inc  57,300.55 $ 10.486  Million 183 
Medtronic Plc  55,463.16 $ 5,269.000  Million 95,000 
Mettler toledo International Inc   54,554.88 $ 905.611  Million 16,600 
Sotera Health Company  54,493.00 $ 163.479  Million 3,000 
West Pharmaceutical Services Inc   52,305.56 $ 564.900  Million 10,800 
3m Company  49,785.12 $ 3,012.000  Million 60,500 
Nephros Inc   48,222.22 $ 1.736  Million 36 
Cormedix Inc   47,794.66 $ 9.129  Million 191 


Date modified: 2026-07-24T15:03:43+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.